Alpa Laboratories Ltd. (ALPA) Share Price Rises 19.52% Today

Alpa Laboratories Ltd. Share Price rises 19.52% today, reaching Rs 78.48 with a market cap of Rs 139.2 crore.

Alpa Laboratories Ltd. Share Price has experienced a significant rise today, closing at Rs 78.48, marking a 19.52% increase from the previous close of Rs 65.66. This substantial gain positions the company within the micro-cap category, with a market capitalisation of Rs 139.2 crore.

The Pharmaceuticals & Drugs industry, where Alpa Laboratories operates, has seen varied performances, but today's rally in Alpa Laboratories Ltd. Share Price stands out. The data confirms the price event, although no specific company catalyst has been identified. Investors and analysts are keenly observing the stock's movement, given its significant gain in a single trading session.

Alpa Laboratories Ltd. (ALPA) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 78.48
Previous Close	Rs 65.66
Today's Change	+Rs 12.82 (+19.52%)
Day Open	Rs 68.64
Day High	Rs 78.48
Day Low	Rs 65.15
Current Volume (BSE)	650
BSE Traded Volume	650
NSE Traded Volume	3,685
Combined NSE + BSE Volume	4,335
Turnover	Rs 0.01 crore
Market Capitalisation	Rs 139.2 crore
Market Cap Category	Micro Cap

Alpa Laboratories Ltd. (ALPA) traded at Rs 78.48. versus the previous close of Rs 65.66, a rise of 19.52%. The stock opened at Rs 68.64, reached Rs 78.48, touched Rs 65.15. Reported volume was 650.

Alpa Laboratories Ltd. (ALPA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 139.2 crore
P/E Ratio	9.2x
P/B Ratio	0.74x
ROE	6.97%
ROCE	10.42%
EPS	Rs 7.13
Dividend Yield	0%

Alpa Laboratories Ltd. was valued at a P/E ratio of 9.2x, a P/B ratio of 0.74x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 6.97% and ROCE of 10.42%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 7.13, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	9.2x
Benchmark Median P/E	26.37x
Benchmark Average P/E	80.74x
Benchmark P/E Range	3.61x to 3,439.3x
Company P/B Ratio	0.74x
Benchmark Median P/B	1.82x
Company ROE	6.97%
Benchmark Median ROE	10.31%
Company ROCE	10.42%
Benchmark Median ROCE	12.96%
Company Market Capitalisation	Rs 139.2 crore
Benchmark Median Market Cap	Rs 147.71 crore

Alpa Laboratories Ltd. (ALPA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Alpa Laboratories Ltd. (ALPA) has a P/E ratio of 9.2x, which is below the benchmark median of 26.37x, a difference of -65.11%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Alpa Laboratories Ltd. (ALPA) has a ROE of 6.97%, which is below the benchmark median of 10.31%, a difference of -32.4%. Alpa Laboratories Ltd. (ALPA) has a ROCE of 10.42%, which is below the benchmark median of 12.96%, a difference of -19.6%.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,921.65	29.31	0.43	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,815.27	39.89	8.12	28.21	26.35
Hikal Ltd.	HIKAL	2,738.51	0	2.23	15.22	16.15
Panacea Biotec Ltd.	PANACEABIO	2,653.99	0	3.04	0	5.36
Sai Parenteral's Ltd.	SAIPARENT	2,476.69	169.37	3.13	13.9	12.97

Alpa Laboratories Ltd. (ALPA) has a P/E ratio of 9.2x compared with the displayed peer median of 29.31x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 6.97% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 10.42% versus the displayed peer median of 12.97%, providing a capital-efficiency comparison. Alpa Laboratories Ltd. (ALPA) has a market capitalisation of Rs 139.2 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Alpa Laboratories Ltd.

Alpa Laboratories Ltd. has captured investor attention due to its significant price rise today. The stock's performance, coupled with its valuation metrics, offers a unique investment opportunity.

• Price Action: 19.52% rise today, exceeding micro-cap threshold.
• Technical Position: Momentum observed in today's trading session.
• Fundamental Context: Low P/E and P/B ratios compared to industry.
• Sector Positioning: Operates in dynamic Pharmaceuticals & Drugs industry.

Investors should monitor Alpa Laboratories Ltd. for further developments in its financial performance and market positioning. The stock's recent price action may lead to increased interest and potential volatility in future trading sessions.

About Alpa Laboratories Ltd.

Alpa Laboratories Ltd. is a prominent player in the Pharmaceuticals & Drugs industry, operating within the Healthcare sector. The company is involved in the manufacturing and distribution of pharmaceutical products, catering to a diverse range of medical needs.

With a focus on quality and innovation, Alpa Laboratories Ltd. has established itself as a reliable provider of healthcare solutions. The company's product portfolio includes a wide array of pharmaceuticals, addressing various therapeutic areas and contributing to its revenue streams.

As a micro-cap company, Alpa Laboratories Ltd. continues to explore growth opportunities within the industry, leveraging its expertise and market presence. The company's recent price rise highlights its potential for future expansion and increased investor interest.

Track Alpa Laboratories Ltd. Share Price on Univest

Use Alpa Laboratories Ltd. (ALPA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors and market enthusiasts can track Alpa Laboratories Ltd. Share Price on Univest for real-time updates and insights. Univest provides comprehensive data on share prices, technical indicators, fundamental ratios, and market insights, helping users make informed investment decisions.

Stay updated with Alpa Laboratories Ltd.'s performance, including 52-week levels and shareholding patterns, through Univest's platform. Explore detailed analysis and market trends to stay ahead in the dynamic world of stock trading.

Frequently Asked Questions

What is the current share price of Alpa Laboratories Ltd.?

Ans. The current share price of Alpa Laboratories Ltd. is Rs 78.48, reflecting a 19.52% increase from the previous close of Rs 65.66. The stock moved 19.52% during the session. The intraday range extended from Rs 65.15 to Rs 78.48.

How much did Alpa Laboratories Ltd. share price rise today?

Ans. Alpa Laboratories Ltd. share price rose by 19.52% today, closing at Rs 78.48, up from the previous close of Rs 65.66. The stock moved 19.52% during the session. The intraday range extended from Rs 65.15 to Rs 78.48.

What is the market capitalisation of Alpa Laboratories Ltd.?

Ans. The market capitalisation of Alpa Laboratories Ltd. is Rs 139.2 crore, categorising it as a micro-cap company in the market. The company operates in the Healthcare sector. Its P/E ratio is 9.2x.

What is Alpa Laboratories Ltd.'s P/E ratio?

Ans. Alpa Laboratories Ltd. has a P/E ratio of 9.2, which is below the industry median of 26.37, indicating a relatively low valuation. The company trades at a P/E ratio of 9.2x.

How does Alpa Laboratories Ltd.'s P/B ratio compare to the industry?

Ans. Alpa Laboratories Ltd.'s P/B ratio is 0.74, lower than the industry median of 1.82, suggesting a more favorable valuation relative to book value. The company trades at a P/E ratio of 9.2x.

What is the ROE of Alpa Laboratories Ltd.?

Ans. The return on equity (ROE) for Alpa Laboratories Ltd. is 6.97%, which is below the industry median of 10.31%. ROE stands at 6.97%. ROCE stands at 10.42%. The relevant peer median ROE is 10.31%.

Who are Alpa Laboratories Ltd.'s peers?

Ans. Peers of Alpa Laboratories Ltd. include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., and Hikal Ltd., among others in the Pharmaceuticals & Drugs industry. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Hikal Ltd.

How does Alpa Laboratories Ltd.'s ROCE compare to the industry?

Ans. Alpa Laboratories Ltd.'s ROCE is 10.42%, which is below the industry median of 12.96%, indicating room for improvement in capital efficiency. ROE stands at 6.97%. ROCE stands at 10.42%. The relevant peer median ROE is 10.31%.